Syndax Pharmaceuticals (SNDX) Stock Forecast & Price Target

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)

$20.74

-0.54 (-2.54%)

(As of 04/17/2024 ET)

Syndax Pharmaceuticals Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Moderate Buy
Based on 10 Analyst Ratings

Analysts' Consensus Price Target

$34.42
65.94% Upside

High Forecast	$45.00
Average Forecast	$34.42
Low Forecast	$23.00

Type	Current Forecast 4/18/23 to 4/17/24	1 Month Ago 3/19/23 to 3/18/24	3 Months Ago 1/18/23 to 1/18/24	1 Year Ago 4/18/22 to 4/18/23
Consensus Rating	Moderate Buy	Moderate Buy	Buy	Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	9 Buy rating(s)	9 Buy rating(s)	11 Buy rating(s)	6 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$34.42	$34.75	$35.83	$33.57
Predicted Upside	65.94% Upside	98.26% Upside	107.85% Upside	36.26% Upside

Get Syndax Pharmaceuticals Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SNDX and its competitors with MarketBeat's FREE daily newsletter.

Ad DTI

Don’t expose yourself to stocks during the week

The S&P 500 just crossed below the 200 day moving average… The Nasdaq is bleeding out… Are we headed for a recession?! If you’ve been in the stock market the last few months, it hasn’t been fun… But what if I told you there was a way to target “BONUS” income just by doing a unique type of trade over the weekend? When the markets are closed. And volatility is minimal.

Click here and I’ll give you all the details.

SNDX Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

SNDX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Syndax Pharmaceuticals Stock vs. The Competition

Type	Syndax Pharmaceuticals	Medical Companies	S&P 500
Consensus Rating Score	2.90	2.68	2.49
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	65.94% Upside	925.79% Upside	12.24% Upside
News Sentiment Rating	Neutral News	Neutral News	Positive News

Recent Analyst Ratings and Stock Forecasts

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
3/27/2024	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$41.00	+91.23%
3/20/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight ➝ Overweight	$31.00 ➝ $34.00	+50.98%
1/31/2024	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Sector Outperform ➝ Sector Perform	$36.00 ➝ $23.00	+13.19%
12/22/2023	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$45.00	+123.33%
10/26/2023	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Buy	$38.00 ➝ $36.00	+184.36%
10/25/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$29.00	+147.44%
Get the Latest News and Ratings for SNDX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Syndax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
10/11/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$30.00	+137.15%
10/3/2023	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target		$42.00 ➝ $43.00	+218.52%
10/3/2023	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target		$32.00 ➝ $28.00	+107.41%
7/26/2023	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target		$31.00 ➝ $34.00	+55.04%
7/26/2023	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Overweight	$31.00 ➝ $34.00	+56.97%
7/25/2023	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy	$34.00 ➝ $36.00	+65.37%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 10:37 PM ET.

SNDX Price Target - Frequently Asked Questions

What is Syndax Pharmaceuticals's consensus rating and price target?: According to the issued ratings of 10 analysts in the last year, the consensus rating for Syndax Pharmaceuticals stock is Moderate Buy based on the current 1 hold rating and 9 buy ratings for SNDX. The average twelve-month price prediction for Syndax Pharmaceuticals is $34.42 with a high price target of $45.00 and a low price target of $23.00. Learn more on SNDX's analyst rating history.
Do Wall Street analysts like Syndax Pharmaceuticals more than its competitors?: Analysts like Syndax Pharmaceuticals more than other Medical companies. The consensus rating score for Syndax Pharmaceuticals is 2.90 while the average consensus rating score for medical companies is 2.68. Learn more on how SNDX compares to other companies.
Is Syndax Pharmaceuticals being downgraded by Wall Street analysts?: Over the previous 90 days, Syndax Pharmaceuticals's stock had 1 downgrade by analysts.

Does Syndax Pharmaceuticals's stock price have much upside?: According to analysts, Syndax Pharmaceuticals's stock has a predicted upside of 89.06% based on their 12-month stock forecasts.
What analysts cover Syndax Pharmaceuticals?: Syndax Pharmaceuticals has been rated by HC Wainwright, JPMorgan Chase & Co., and Scotiabank in the past 90 days.

Stock Ratings Reports and Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

This page (NASDAQ:SNDX) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Syndax Pharmaceuticals (SNDX) Stock Forecast & Price Target

Syndax Pharmaceuticals Consensus Analyst Rating and Stock Price Forecast (2024)

Analysts' Consensus Rating

Analysts' Consensus Price Target

SNDX Analyst Ratings By Month

SNDX Price Targets by Month

Syndax Pharmaceuticals Stock vs. The Competition

Recent Analyst Ratings and Stock Forecasts

SNDX Price Target - Frequently Asked Questions

Stock Ratings Reports and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info